1. Home
  2. RANI vs CASI Comparison

RANI vs CASI Comparison

Compare RANI & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • CASI
  • Stock Information
  • Founded
  • RANI 2012
  • CASI 1991
  • Country
  • RANI United States
  • CASI China
  • Employees
  • RANI N/A
  • CASI N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RANI Health Care
  • CASI Health Care
  • Exchange
  • RANI Nasdaq
  • CASI Nasdaq
  • Market Cap
  • RANI 24.2M
  • CASI 24.9M
  • IPO Year
  • RANI 2021
  • CASI 1996
  • Fundamental
  • Price
  • RANI $1.90
  • CASI $1.17
  • Analyst Decision
  • RANI Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • RANI 6
  • CASI 1
  • Target Price
  • RANI $8.67
  • CASI $4.00
  • AVG Volume (30 Days)
  • RANI 21.6M
  • CASI 28.1K
  • Earning Date
  • RANI 11-06-2025
  • CASI 11-14-2025
  • Dividend Yield
  • RANI N/A
  • CASI N/A
  • EPS Growth
  • RANI N/A
  • CASI N/A
  • EPS
  • RANI N/A
  • CASI N/A
  • Revenue
  • RANI $1,200,000.00
  • CASI $26,846,000.00
  • Revenue This Year
  • RANI N/A
  • CASI N/A
  • Revenue Next Year
  • RANI N/A
  • CASI N/A
  • P/E Ratio
  • RANI N/A
  • CASI N/A
  • Revenue Growth
  • RANI N/A
  • CASI 21.72
  • 52 Week Low
  • RANI $0.39
  • CASI $1.09
  • 52 Week High
  • RANI $3.87
  • CASI $5.69
  • Technical
  • Relative Strength Index (RSI)
  • RANI 54.20
  • CASI 33.09
  • Support Level
  • RANI $1.77
  • CASI $1.29
  • Resistance Level
  • RANI $2.16
  • CASI $1.48
  • Average True Range (ATR)
  • RANI 0.35
  • CASI 0.13
  • MACD
  • RANI -0.07
  • CASI -0.01
  • Stochastic Oscillator
  • RANI 41.74
  • CASI 14.41

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: